Literature DB >> 18653703

Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer.

C Wan1, Q Meng, Z Yang, X Tu, C Feng, X Tang, C Zhang.   

Abstract

BACKGROUND: European Organization for Research and Treatment quality of life (QOL) questionnaire (QLQ-C30) has been used frequently and many language versions have been developed, including the simplified Chinese version. It is important to study psychometric properties of the simplified Chinese version from the clinical standpoint. PATIENTS AND METHODS: The simplified Chinese version of the QLQ-C30 was used in a longitudinal study of 600 patients with five types of cancer: lung, breast, head and neck, colorectal, and stomach. The psychometric properties of the scale were evaluated by indicators of validity and reliability coefficients such as Cronbach's alpha and Pearson's correlation coefficient r, standardized response mean (SRM), correlational analysis, t-tests, and structural equation models.
RESULTS: Correlation and structural equation model analyses confirmed good construct validity with root mean square error of approximation 0.054, standardized root mean square residual 0.037, non-normed fit index 0.972, and comparative fit index 0.980. The alpha coefficients for all domains are >0.7 except for cognitive functioning (0.49). The test-retest reliability coefficients for most domains are >0.80 except for appetite loss (0.77) and diarrhea (0.75). The QOL score changes after treatments were of statistical significance with higher or moderate SRM in most domains.
CONCLUSION: The simplified Chinese version of QLQ-C30 has good validity, reliability, and responsiveness and can be used to measure QOL for Chinese cancer patients.

Entities:  

Mesh:

Year:  2008        PMID: 18653703      PMCID: PMC2733108          DOI: 10.1093/annonc/mdn417

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  26 in total

1.  Assessing reproducibility for interval data in health-related quality of life questionnaires: which coefficient should be used?

Authors:  Peter Schuck
Journal:  Qual Life Res       Date:  2004-04       Impact factor: 4.147

2.  Validation of the Korean version of the EORTC QLQ-C30.

Authors:  Y H Yun; Y S Park; E S Lee; S M Bang; D S Heo; S Y Park; C H You; K West
Journal:  Qual Life Res       Date:  2004-05       Impact factor: 4.147

3.  Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach.

Authors:  G R Norman; P Stratford; G Regehr
Journal:  J Clin Epidemiol       Date:  1997-08       Impact factor: 6.437

4.  Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement.

Authors:  M Groenvold; M C Klee; M A Sprangers; N K Aaronson
Journal:  J Clin Epidemiol       Date:  1997-04       Impact factor: 6.437

5.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.

Authors:  M A Sprangers; M Groenvold; J I Arraras; J Franklin; A te Velde; M Muller; L Franzini; A Williams; H C de Haes; P Hopwood; A Cull; N K Aaronson
Journal:  J Clin Oncol       Date:  1996-10       Impact factor: 44.544

6.  The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.

Authors:  B Bergman; N K Aaronson; S Ahmedzai; S Kaasa; M Sullivan
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

7.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Authors:  D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

8.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

9.  Sensitivity to change of rheumatoid arthritis clinical trial outcome measures.

Authors:  J J Anderson; M C Chernoff
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

10.  The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group.

Authors:  M A Sprangers; A Cull; M Groenvold; K Bjordal; J Blazeby; N K Aaronson
Journal:  Qual Life Res       Date:  1998-05       Impact factor: 4.147

View more
  35 in total

1.  Therapeutic effect of Jinlongshe Granule () on quality of life of stage IV gastric cancer patients using EORTC QLQ-C30: A double-blind placebo-controlled clinical trial.

Authors:  Da-zhi Sun; Jian-peng Jiao; Xuan Zhang; Jing-yu Xu; Min Ye; Li-juan Xiu; Ying Zhao; Ye Lu; Xuan Liu; Jing Zhao; Jun Shi; Zhi-feng Qin; Pin-kang Wei
Journal:  Chin J Integr Med       Date:  2014-11-16       Impact factor: 1.978

2.  Further evaluation of the EORTC QLQ-C30 psychometric properties in a large Brazilian cancer patient cohort as a function of their educational status.

Authors:  Carlos Eduardo Paiva; Estela Cristina Carneseca; Eliane Marçon Barroso; Mayara Goulart de Camargos; Ana Camila Callado Alfano; Fernanda Capella Rugno; Bianca Sakamoto Ribeiro Paiva
Journal:  Support Care Cancer       Date:  2014-03-21       Impact factor: 3.603

3.  Cognitive challenges while at work and work output in breast cancer survivors employed in a rapidly evolving economy.

Authors:  Andy S K Cheng; Yingchun Zeng; Xiangyu Liu; Shaxin Liu; Stella W C Cheng; Cindy T T Kwok; Raymond C K Chung; Jianfei Xie; Michael Feuerstein
Journal:  J Cancer Surviv       Date:  2018-09-18       Impact factor: 4.442

Review 4.  Pharmaceutical care and health related quality of life outcomes over the past 25 years: Have we measured dimensions that really matter?

Authors:  Mohammed A Mohammed; Rebekah J Moles; Timothy F Chen
Journal:  Int J Clin Pharm       Date:  2018-01-10

Review 5.  Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations.

Authors:  Jaishri O Blakeley; Stephen Joel Coons; John R Corboy; Nancy Kline Leidy; Tito R Mendoza; Jeffrey S Wefel
Journal:  Neuro Oncol       Date:  2016-03       Impact factor: 12.300

6.  Development and validation of the simplified Chinese version of EORTC QLQ-H&N35 for patients with head and neck cancer.

Authors:  Zheng Yang; Qiong Meng; Jiahong Luo; Qian Lu; Xiaojiang Li; Gaofeng Li; Chonghua Wan
Journal:  Support Care Cancer       Date:  2011-08-18       Impact factor: 3.603

7.  Quality of life and symptoms in patients with malignant diseases admitted to a comprehensive cancer centre.

Authors:  Annette Sand Strömgren; Carsten Utoft Niemann; Ulla Brix Tange; Hanne Farholt; Nan M Sonne; Lena Ankersen; Lisbet Kristensen; Lisbeth Bendixen; Mogens Groenvold; Morten Aagaard Petersen; Mie Nordly; Lona Christrup; Per Sjøgren; Geana Paula Kurita
Journal:  Support Care Cancer       Date:  2014-02-19       Impact factor: 3.603

8.  The use of multiple languages in a technology-based intervention study: A discussion paper.

Authors:  Eun-Ok Im; Soo Jin Lee; Yun Hu; Ching-Yu Cheng; Atsumi Iikura; Ayako Inohara; Sarah Kim; Yuko Hamajima; Seon-Ae Yeo; Eunice Chee; Wonshik Chee
Journal:  Appl Nurs Res       Date:  2017-10-16       Impact factor: 2.257

9.  Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases.

Authors:  Lei Zhang; Yan-Jun Su; Jia-Yue Chen; Zhi-Chao Liao; Zhi-Qin Luo; Shu-Min Xie; Jing Zhang; Yun-Shou Lin; Hui Guo; Wei-Lin Sun; Begüm Pekbay; Adam R Miller; Le Luo; Yu-Hua Rui; Mo-Han Li; Chang-Li Wang
Journal:  Support Care Cancer       Date:  2015-08-06       Impact factor: 3.603

10.  Health - related quality of life of Kuwaiti women with breast cancer: a comparative study using the EORTC Quality of Life Questionnaire.

Authors:  Shafika A Alawadi; Jude U Ohaeri
Journal:  BMC Cancer       Date:  2009-07-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.